Neogenomics (NEO) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Neogenomics (NEO) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.08% |
| Mar 31, 2026 | -73.12% |
| Dec 31, 2025 | 63.58% |
| Sep 30, 2025 | 39.84% |
| Jun 30, 2025 | -73.95% |
| Mar 31, 2025 | -69.17% |
| Dec 31, 2024 | 13.42% |
| Sep 30, 2024 | 5.06% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | -88.89% |
| Dec 31, 2023 | 22.63% |
| Sep 30, 2023 | 23.90% |
| Jun 30, 2023 | 20.99% |
| Mar 31, 2023 | -35.74% |
| Dec 31, 2022 | 38.44% |
| Sep 30, 2022 | -4.39% |
| Jun 30, 2022 | 28.55% |
| Mar 31, 2022 | -18.32% |
| Dec 31, 2021 | -105.22% |
| Sep 30, 2021 | -126.82% |